Showing results (21-30 of 105) with videos related to
Sort By:
Pageof 11
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|July 26, 2000
Clinical mutations in the L1 neural cell adhesion molecule affect cell-surface expressionH D Moulding, R L Martuza, S D RabkinJournal of Neurosurgery|January 1, 1977
Characteristics of human optic gliomas in tissue cultureR L Martuza, P L Kornblith, T M LiszczakNeurosurgery|December 1, 1981
Specific estradiol binding in schwannomas, meningiomas, and neurofibromasR L Martuza, D T MacLaughlin, R G OjemannHuman Gene Therapy|December 10, 1999
Corticosteroid administration does not affect viral oncolytic activity, but inhibits antitumor immunity in replication-competent herpes simplex virus tumor therapyT Todo, S D Rabkin, A Chahlavi, et al.Human Gene Therapy|February 27, 1999
Herpes simplex virus as an in situ cancer vaccine for the induction of specific anti-tumor immunityM Toda, S D Rabkin, H Kojima, et al.Neurosurgery|November 1, 1994
Antisense expression of protein kinase C alpha inhibits the growth and tumorigenicity of human glioblastoma cellsS Ahmad, T Mineta, R L Martuza, et al.Journal of Immunology (Baltimore, Md. : 1950)|May 9, 1998
In situ cancer vaccination: an IL-12 defective vector/replication-competent herpes simplex virus combination induces local and systemic antitumor activityM Toda, R L Martuza, H Kojima, et al.Acta Neuropathologica|January 1, 1989
Sarcomatous proliferation of the vasculature in a subependymomaD N Louis, E T Hedley-Whyte, R L MartuzaNeoplasia (New York, N.Y.)|August 10, 2000
Replication-competent herpes simplex virus vector G207 and cisplatin combination therapy for head and neck squamous cell carcinomaA Chahlavi, T Todo, R L Martuza, et al.Journal of Virology|July 1, 1997
Transcriptional targeting of herpes simplex virus for cell-specific replicationS Miyatake, A Iyer, R L Martuza, et al.Pageof 11